Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The Company has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 374.24% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.28M.
Overvalued
The company’s latest PE is 0.23, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 215.62K shares, decreasing 13.10% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 7.10K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.10.